The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancerChiranjib Chakraborty, Sang‐Soo Lee|Oncotarget|2018Cited by 104
Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesisJu‐Suk Nam, Sang‐Soo Lee|Korean Journal of Physiology and Pharmacology|2018Cited by 15
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae‐Won Hyun, Ho Jin Kim, Jeeyoung Oh et al.|Multiple Sclerosis Journal|2020Cited by 14
Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorderEun Bin Cho, Ju‐Hong Min, Patrick Waters et al.|Frontiers in Immunology|2024Cited by 10
Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating DisordersHye Lim Lee, Byoung Joon Kim, Jin‐Woo Park et al.|Diagnostics|2021Cited by 5